Table 14: Myopia and Risk of Prevalent POAG by Multivariate Analysis.

Study	Age (years) Mean (SD)[Range]	OR (95% CI)	Definition of Myopia (Spherical Equivalent, S.E.)	Dose Response Effect Found?
Chennai Glaucoma Study (36)	53.8(10.7)	*0.68 (0.40-1.17)	S.E. worse than -0.5 D in phakic eye	Not assessed
Aravind Comprehensive Eye Survey (5)	Median:51.0 [40-90]	†Mild:2.9 (1.3-6.9) †Moderate:2.1 (1.0-4.6) †Severe3.9 (1.6-9.5)	S.E. worse than -0.5D in either phakic eye No definitions of mild, moderate or severe reported in study.	No
Beaver Dam Eye Study (45)	60.6(11.3)	‡1.6 (1.1, 2.4) (2 eyes) ‡1.6 (0.9-2.6) (right eyes only)	S.E. of -1.00D or worse	No
Blue Mountains Eye Study(38)	Males: 75.9 [49-97] Females: 65.9 [52-96]	§2.1 (1.2-3.8) ||2.3 (1.3-4.1)	S.E. of -1.00D or worse	Yes as assessed in people ≥ 60 years of age
		||¶2.3(1.3-4.1)	Low: S.E ≥-1.00 to < -3.0 D
		||¶3.3(1.7-6.4)	Moderate to High: S.E. ≥ -3.00 D

^*Adjusted for age, gender, IOP, central corneal thickness and hypertension

^†Adjusted for age, gender, diabetes, hypertension, pseudoexfoliation, myopia

^‡Adjusted for age, gender, education, hypertension, diabetes

^§Age and gender adjusted

^||Adjusted for gender, age, glaucoma family history, diabetes, hypertension, history of typical migraine, steroid use, and presence of pseudoexfoliation.

^¶Low, and moderate to severe Myopia for people 60+ years of age. Insufficient data for persons less than 60 years of age to include in analyses.